• 1
    Stirling Y, Woolf L, North WRS, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemost 1984;52: 176182.
  • 2
    Åstedt B. The placenta and haemostatic balance. In: RedmanCWG, SargentIL, StarkeyPM, editors. The Human Placenta. Oxford , UK : Blackwell, 1993: 291309.
  • 3
    Higgins JR, Walshe JJ, Darling MRN, Norris L, Bonnar J. Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies. Am J Obstet Gynecol 1998;179: 520526.
  • 4
    Letsky EA. Haemostatic problems associated with pregnancy. In: EdmondsDK, editors. Dewhurst's Textbook of Obstetrics and Gynaecology for Postgraduates. Oxford , UK : Blackwell, 1999: 210237.
  • 5
    Clark P, Brennand J, Conkie JA, McCall F, Greer IA, Walker ID. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998;79: 11661170.
  • 6
    Declerck PJ, Alessi MC, Verstreken M, Kruithof EKO, Juhan-Vague I, Collen D. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1988;71: 220225.
  • 7
    Estelles A, Gilabert J, Aznar J, Loskutoff DJ, Schleef RR. Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia. Blood 1989;74: 13321338.
  • 8
    Cadroy Y, Grandjean H, Pichon J, et al. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynaecol 1993;100: 416420.
  • 9
    Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol 1994;101: 488492.
  • 10
    Roberts JM. Pregnancy-related hypertension. In: CreasyRK, ResnikR, editors. Maternal–Fetal Medicine: Principles and Practice. Philadelphia , USA : W.B. Saunders, 1984: 703752.
  • 11
    Perry KG, Martin JN. Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia. Clin Obstet Gynecol 1992;35: 338350.
  • 12
    Branch DW, Porter TF. Hypertensive disorders of pregnancy. In: ScottJR, SaiaPJD, HammondCB, SpellacyWN, editors. Danforth's Obstetrics and Gynecology. Philadelphia , USA : Lippincott Williams & Wilkins, 1999: 309326.
  • 13
    Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998;16: 515.
  • 14
    Robson SC. Hypertension and renal disease in pregnancy. In: EdmondsDK, editors. Dewhurst's Textbook of Obstetrics and Gynaecology for Postgraduates. Oxford , UK : Blackwell, 1999: 166185.
  • 15
    Rodgers GM. Hemostatic properties of normal and perturbed vascular cells. FASEB J 1988;2: 116123.
  • 16
    Sattar N, Greer IA, Rumley A, et al. A longitudinal study of the relationships between haemostatic, lipid, and oestradiol changes during normal human pregnancy. Thromb Haemost 1999;81: 7175.
  • 17
    Ballegeer V, Mombaerts P, Declerck PJ, Spitz B, Assche FAV, Collen D. Fibrinolytic response to venous occlusion and fibrin fragment D-dimer levels in normal and complicated pregnancy. Thromb Haemost 1987;58: 10301032.
  • 18
    Estelles A, Gilabert J, España F, Aznar J, Galbis M. Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia. Am J Obstet Gynecol 1991;165: 138142.
  • 19
    Shaarawy M, Didy HE. Thrombomodulin, plasminogen activator inhibitor type 1 (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia. Int J Gynaecol Obstet 1996;55: 135139.
  • 20
    Schjetlein R, Abdelnoor M, Haugen G, Husby H, Sandset PM, Wisløff F. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia. Acta Obstet Gynecol Scand 1999;78: 191197.
  • 21
    Schjetlein R, Haugen G, Wisløff F. Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation. Acta Obstet Gynecol Scand 1997;76: 541546.
  • 22
    Friedman SA, Schiff E, Emeis JJ, Dekker GA, Sibai BM. Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Obstet Gynecol 1995;172: 202203.
  • 23
    Bellart J, Gilabert R, Angles A, et al. Tissue factor levels and high ratio of fibrinopeptide A:D-dimer as a measure of endothelial procoagulant disorder in pre-eclampsia. Br J Obstet Gynaecol 1999;106: 594597.
  • 24
    Raghunath PN, Tomaszewski JE, Brady ST, Caron RJ, Okada SS, Barnathan ES. Plasminogen activator system in human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1995;15: 14321443.
  • 25
    Murai JT, Muzykanskiy E, Taylor RN. Maternal and fetal modulators of lipid metabolism correlate with the development of preeclampsia. Metabolism 1997;46: 963967.
  • 26
    Barron WM, Heckerling P, Hibbard JU, Fisher S. Reducing unnecessary coagulation testing in hypertensive disorders of pregnancy. Obstet Gynecol 1999;94: 364370.
  • 27
    Kobayashi T, Tokunaga N, Sugimura M, et al. Coagulation/fibrinolysis disorder in patients with severe preeclampsia. Semin Thromb Hemost 1999;25: 451454.